Bioresorbable Stents

Global Market Trajectory & Analytics

MCP10697

EXECUTIVE ENGAGEMENTS

POOL

5202
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

832
Interactions with Platform & by Email

PARTICIPANTS

156
Unique # Participated

VALIDATIONS

34
Responses Validated*

COMPANIES

25
Responses Validated*
* Login for a full stack data experience

DATE

MAY 2021

TABLES

32

PAGES

125

EDITION

7

PRICE

USD 4950

CODE

MCP10697


COMPETITIVE METRICS

COMPANY

D S N T

% *

Abbott Laboratories, Inc.

Alvimedica Saglik Ekipmanlari Pazarlama Satis ve Dagitim A.S.

AMG International

Arterial Remodeling Technologies SA

Arterius Ltd.

Biosensors International Group Ltd.

Biotronik SE & Co. KG

Boston Scientific Corporation

Elixir Medical Corporation

Endocor GmbH

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Bioresorbable Stents Market to Reach $618.8 Million by 2026

Bioresorbable stents represent the latest innovation in angioplasty, the medical procedure wherein a round, tubular, metallic stent is inserted into a clogged artery to open it up and enhance the flow of blood. Growth in the global market is set to be fueled by increasing prevalence of cardiovascular diseases such as peripheral artery and coronary artery diseases, increasing elderly population, and fast increasing obese population. Additional growth factors include an increase in number of PCI procedures performed each year, more patients favoring minimally invasive therapies, higher adoption of these stents by patients and physicians alike, and greater number of clinical trials evaluating the use of bioabsorbable stents. The popularity of bioabsorbable stents is influenced by the elimination of the need to perform stent-in-stent procedures, elimination of the requirement for dual anti-platelet therapies, higher degree of effectiveness in treating coronary artery diseases, and the possibility of achieving accurate stent placement as well as cost-effectiveness of the treatment.

Amid the COVID-19 crisis, the global market for Bioresorbable Stents estimated at US$316.7 Million in the year 2020, is projected to reach a revised size of US$618.8 Million by 2026, growing at a CAGR of 11.8% over the analysis period. Polymer-based Bioresorbable Stents, one of the segments analyzed in the report, is projected to reach US$499.5 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metal-based Bioresorbable Stents segment is readjusted to a revised 10% CAGR for the next 7-year period. Bioabsorbable polymer stents represent the largest segment as these stents are made using materials that get completely dissolved in the body, and hence find use in procedures with respect to both coronary artery and peripheral artery diseases. Metal-based bioresorbable scaffolds, such as magnesium and iron, are preferred over polymer-based biodegradable stents, due to their superior performance. Magnesium-based bioabsorbable stents minimize thrombogenicity and cause rapid endothelialization, and involve a lesser degradation period.

European Market is Estimated at $190.2 Million in 2021, While Asia-Pacific is Forecast to Reach $159.8 Million by 2026

Bioresorbable Stents market in Europe is estimated at US$190.2 Million in the year 2021. Asia-Pacific is forecast to reach a projected market size of US$159.8 Million by the year 2026 trailing a CAGR of 10.3% over the analysis period. Rest of World is forecast to grow at 11.1% over the analysis period. Europe represents the largest regional market and growth in the region is being spurred by higher prevalence of cardiovascular diseases, an aging population at risk of these diseases, greater awareness with regard to and increased adoption of bioabsorbable stents. The significant demand for technologically advanced treatments for cardiovascular problems boosts usage of bioresorbable stents. Growing awareness with respect to peripheral and coronary artery diseases and an increase in number of people with higher cholesterol levels, a major risk factor for cardiovascular diseases, is helping the demand expand for bioabsorbable stents in Asia-Pacific region.

SELECT PLAYERS

Abbott Laboratories; Arterius Limited; BIOTRONIK SE & Co. KG; Boston Scientific Corporation; Elixir Medical Corp.; Kyoto Medical Planning Co., Ltd.; LEPU MEDICAL TECHNOLOGY CO., LTD.; Meril Life Sciences Pvt. Ltd.; REVA Medical, Inc.

SEGMENTS

» Material (Polymer-based, Metal-based) » Application (Coronary Artery Disease/CAD, Peripheral Artery Disease/PAD) » End-Use (Hospitals, Cardiovascular Centers)

GEOGRAPHIES

» World » Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Coronary Artery Disease (CAD) – A Perspective
Causes and Symptoms
Treatment Options for Coronary Artery Disease
Percutaneous Coronary Intervention (PCI)
Coronary Stenting
Types of Coronary Stents
Other Treatment Options for Coronary Heart Disease
Coronary Artery Bypass Grafting (CABG)
Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)
TransMyocardial Laser Revascularization (TMR)
Peripheral Arterial Disease: Understanding the Stealthy Peril
Treatment for PAD
Stenting- A Treatment Option for PAD
BioResorbable Stents – A Prelude
Bioresorbable Vascular Scaffolds: Advantages and Challenges
Bioresorbable Stents – A Revolutionary Technology, Riddled with Controversies
Abbott Stops Sales of the Once Promising ‘Absorb’ Bioresorbable Stents due to Adverse Events
Impact of Abbott’s Withdrawal of Absorb on the Bioresorbable Stent Industry
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Impact of COVID – 19 on Coronary Stents Market
Impact on Supply Chain
Impact of COVID-19 Outbreak on Elective Surgeries
Global Bioresorbable Stents Market Buckles under COVID-19 Strain
GLOBAL MARKET OVERVIEW
Global Bioresorbable Stents Set to Witness Growth in Future
Europe Dominates, Asia-Pacific Exhibits Fastest Growth
CAD Constitutes the Leading Application
Metallic Vs. Polymer-based Stents
Bioabsorbable Metallic Stents
Bioabsorbable Polymer Stents
Disappointing Results by Absorb to Increase Focus on Metallic Stents
Availability of Alternative Treatments – Hindrance to Market Growth
Market Challenges
MARKET OUTLOOK
Bioresorbable and Integrated Biosensor Technology to Redefine Future of Vascular Stents
The Future of BRS Technology
COMPETITION
Select Approved Bioresorbable Scaffolds
Select Bioresorbable Stents in Pipeline
Abbott Revives Bioresorbable Stent Clinical Trials to Evaluate New Esprit Scaffold
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Polymeric Resorbable Scaffolds Hold a Major Market Share
The Absorb BRS program
Desaminotyrosine Polycarbonate-based BRS
The FANTOM program
Magnesium-based BRS
The Magmaris program
Iron-based BRS
Global Menace of Coronary Artery Disease (CAD) – A Major Growth Driver
EXHIBIT: Global Annual Medical Cost of CVD in the United States: 2015-2030
EXHIBIT: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Ageing Demographics and Longer Life Expectancy Bolsters Market Growth
EXHIBIT: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Rising Middle Class Population Aids Growth
EXHIBIT: Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020P & 2030P
Rising Healthcare Expenditure: Opportunities in Store
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
EXHIBIT 3: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Risk of CAD in Obesity Offers Prospects for Coronary Stenting
EXHIBIT: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Diabetics at Higher Risk of Heart Diseases
TABLE 15: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040
The Hypertension-Cholesterol Link to Drive Demand
EXHIBIT: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
Metal Bioresorbable scaffolds Exhibit Improved Performance Compared to Polymer Stents
Metal Stents Vis-à-Vis Other Stents
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Bioresorbable Stents by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Bioresorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Polymer-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Polymer-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Metal-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Metal-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Coronary Artery Disease/CAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Coronary Artery Disease/CAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Peripheral Artery Disease/PAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Peripheral Artery Disease/PAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Cardiovascular Centers by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cardiovascular Centers by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027
Europe Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027
Europe Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027
Rest of World Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027
Rest of World Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027
Total Companies Profiled: 25

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com